{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-016272","form_type":"8-K","ticker":"NRXP","cik":"0001719406","company_name":"NRX Pharmaceuticals, Inc.","filed_at":"2025-05-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.460809+00:00","generated_at":"2026-05-21T16:37:51.352689+00:00","sec_items":["8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"NRx Pharmaceuticals subsidiary HOPE signs definitive agreement to acquire Kadima Neuropsychiatry Institute","bullets":["Kadima is a profitable interventional psychiatry clinic in La Jolla, CA, expected to serve as clinical model for HOPE network.","Dr. David Feifel, Kadima founder, to join HOPE as Chief Medical Innovation Officer upon closing.","Acquisition expected to be accretive to revenue and EBITDA for NRx and HOPE.","Closing subject to customary conditions and finalization of financing; further details to follow.","Kadima is a leading investigative site for CNS and psychedelic research, including ketamine and TMS."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-016272","json":"https://secwatch.observer/filing/0001437749-25-016272.json","markdown":"https://secwatch.observer/filing/0001437749-25-016272.md","text":"https://secwatch.observer/filing/0001437749-25-016272.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1719406/000143774925016272/0001437749-25-016272-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1719406/000143774925016272/nrxp20250513_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T16:37:51.352689+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}